Insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection

Arab Journal of Gastroenterology

Volumn 11, Issue 1, 2010, Pages 30-34

  Abdel Azziz, Mohamed Yaqoot ^a   Zalata, Kkaled Refaat ^a   El Bendary, Mahmoud M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Diabetes mellitus; HCV; Insulin resistance; Liver cirrhosis

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HOMEOSTASIS; HUMAN; HYPERTRANSAMINASEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 77955305835     PISSN: 16871979     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajg.2010.01.004     Document Type: Article

References (30)

1. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20(1):1-16.
2. El Sayed N.M., Gomatos P.J., Rodier G.R., et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 1996, 55(2):179-184.
3. Abdel Wahab M.F., Zakaria S., Kamel M., et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg 1994, 51(5):563-567.
4. Marcellin P. Hepatitis C: the clinical spectrum of the disease. J Hepatol 1999, 31(Suppl. 1):9-16.
5. Allison M.E., Wreghitt T., Palmer C.R., et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994, 21(6):1135-1139.
6. Mehta S.H., Brancati F.L., Sulkowski M.S., et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000, 133(8):592-599.
7. El Zayadi A.R., Selim O.E., Hamdy H., et al. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998, 19(4):141-144.
8. Grimbert S., Valensi P., Levy Marchal C., et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996, 20(6-7):544-548.
9. Warram J.H., Martin B.C., Krolewski A.S., et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990, 113(12):909-915.
10. Song Y., Manson J.E., Tinker L., et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic Cohort of women: the women's health initiative observational study. Diabetes Care 2007, 30(7):1747-1752.
11. Monto A., Alonzo J., Watson J.J., et al. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol. Hepatology 2002, 36(3):729-736.
12. Czaja A.J., Carpenter H.A., Santrach P.J., et al. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998, 29(2):198-206.
13. Ratziu V., Munteanu M., Charlotte F., et al. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol 2003, 39(6):1049-1055.
14. Martinot Peignoux M., Boyer N., Cazals Hatem D., et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology 2001, 34(5):1000-1005.
15. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21(12):2191-2192.
16. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003, 125(6):1695-1704.
17. Friedman S.L. Liver fibrosis - from bench to bedside. J Hepatol 2003, 38(Suppl 1):S38-S53.
18. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet 1997, 349(9055):825-832.
19. Puoti C., Magrini A., Stati T., et al. Clinical, histological and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997, 26(6):1393-1398.
20. Schmidt A.M., Hori O., Brett J., et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994, 14(10):1521-1528.
21. Fehrenbach H., Weiskirchen R., Kasper M., et al. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 2001, 34(5):943-952.
22. Fukui M., Kitagawa Y., Nakamura N., et al. Response to oncul: Insulin sensitivity in patients with chronic hepatitis C virus infection. Diabetes Care 2002, 25(10):1900-1-1901-2. discussion.
23. Maeno T., Okumura A., Ishikawa T., et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003, 18(12):1358-1363.
24. El Sammak M., Refai W., El Sawaf A., et al. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients. Curr Med Res Opin 2005, 21(4):527-534.
25. Yoneda M., Saito S., Ikeda T., et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J Viral Hepatol 2007, 14(9):600-607.
26. Kawaguchi T., Yoshida T., Harada M., et al. Hepatitis C virus Down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004, 165(5):1499-1508.
27. Hui C.K., Belaye T., Montegrande K., et al. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003, 38(4):511-517.
28. Fartoux L., Poujol Robert A., Guechot J., et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005, 54(7):1003-1008.
29. Paradis V., Perlemuter G., Bonvoust F., et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 2001, 34(4 Pt 1):738-744.
30. D'Souza R., Sabin C.A., Foster G.R. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005, 100(7):1509-1515.